<s id="wsj_2078.1"> 21
2 	 0 	 NP[nb]/N 	 1 	 vaccine An
2 	 1 	 N/N 	 1 	 vaccine experimental
2 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 vaccine can
2 	 4 	 (S[b]\NP)/NP 	 1 	 vaccine alter <XB>
3 	 20 	 (S[dcl]\S[dcl])\NP 	 1 	 can said
4 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 alter can
7 	 4 	 (S[b]\NP)/NP 	 2 	 response alter
7 	 5 	 NP[nb]/N 	 1 	 response the
7 	 6 	 N/N 	 1 	 response immune
7 	 8 	 (NP\NP)/NP 	 1 	 response of
9 	 8 	 (NP\NP)/NP 	 2 	 people of
9 	 10 	 (S[pss]\NP)/PP 	 1 	 people infected <XB>
11 	 10 	 (S[pss]\NP)/PP 	 2 	 with infected
14 	 11 	 PP/NP 	 1 	 virus with
14 	 12 	 NP[nb]/N 	 1 	 virus the
14 	 13 	 N/N 	 1 	 virus AIDS
19 	 16 	 NP[nb]/N 	 1 	 scientist a
19 	 17 	 N/N 	 1 	 scientist prominent
19 	 18 	 N/N 	 1 	 scientist U.S.
19 	 20 	 (S[dcl]\S[dcl])\NP 	 2 	 scientist said
<\s>
<s id="wsj_2078.2"> 12
2 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 that does
2 	 5 	 (S[b]\NP)/S[dcl] 	 1 	 that mean <XB>
3 	 0 	 S/S 	 1 	 does However
3 	 4 	 (S\NP)\(S\NP) 	 2 	 does n't
5 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 mean does
6 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 they can
6 	 8 	 (S[b]\NP)/PP 	 1 	 they benefit <XB>
7 	 5 	 (S[b]\NP)/S[dcl] 	 2 	 can mean
8 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 benefit can
9 	 8 	 (S[b]\NP)/PP 	 2 	 from benefit
11 	 9 	 PP/NP 	 1 	 vaccine from
11 	 10 	 NP[nb]/N 	 1 	 vaccine the
<\s>
<s id="wsj_2078.3"> 38
1 	 0 	 NP[nb]/N 	 1 	 effectiveness Its
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 effectiveness ca
1 	 5 	 S[pss]\NP 	 1 	 effectiveness determined <XB>
2 	 3 	 (S\NP)\(S\NP) 	 2 	 ca n't
4 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be ca
5 	 4 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 determined be
5 	 6 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 determined until
5 	 19 	 ((S\NP)\(S\NP))/PP 	 2 	 determined according
10 	 7 	 NP[nb]/N 	 1 	 trial a
10 	 8 	 N/N 	 1 	 trial large
10 	 9 	 N/N 	 1 	 trial clinical
10 	 11 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 trial is
10 	 12 	 S[pss]\NP 	 1 	 trial undertaken <XB>
11 	 6 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 is until
12 	 11 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 undertaken is
12 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 undertaken by
12 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 undertaken in
15 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 Army by
15 	 14 	 NP[nb]/N 	 1 	 Army the
17 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 January in
20 	 19 	 ((S\NP)\(S\NP))/PP 	 3 	 to according
22 	 20 	 PP/NP 	 1 	 Redfield to
22 	 21 	 N/N 	 1 	 Redfield Robert
24 	 20 	 PP/NP 	 1 	 chief to
24 	 25 	 (NP\NP)/NP 	 1 	 chief of
24 	 31 	 (NP\NP)/NP 	 1 	 chief at
30 	 25 	 (NP\NP)/NP 	 2 	 research of
30 	 26 	 N/N 	 1 	 research acquired
30 	 27 	 N/N 	 1 	 research immune
30 	 28 	 N/N 	 1 	 research deficiency
30 	 29 	 N/N 	 1 	 research syndrome
35 	 31 	 (NP\NP)/NP 	 2 	 Institute at
35 	 32 	 N/N 	 1 	 Institute Walter
35 	 33 	 N/N 	 1 	 Institute Reed
35 	 34 	 N/N 	 1 	 Institute Army
35 	 36 	 (NP\NP)/NP 	 1 	 Institute of
37 	 36 	 (NP\NP)/NP 	 2 	 Research of
<\s>
<s id="wsj_2078.4"> 33
1 	 0 	 N/N 	 1 	 Redfield Dr.
1 	 2 	 (NP[nb]/N)\NP 	 2 	 Redfield 's
3 	 2 	 (NP[nb]/N)\NP 	 1 	 report 's
3 	 4 	 (NP\NP)/NP 	 1 	 report on
3 	 21 	 S[dcl]\NP 	 1 	 report came
6 	 4 	 (NP\NP)/NP 	 2 	 experiments on
6 	 5 	 N/N 	 1 	 experiments early
6 	 7 	 (S[ng]\NP)/NP 	 1 	 experiments using <XB>
10 	 7 	 (S[ng]\NP)/NP 	 2 	 vaccine using
10 	 8 	 NP[nb]/N 	 1 	 vaccine an
10 	 9 	 N/N 	 1 	 vaccine AIDS
10 	 11 	 S[pss]\NP 	 1 	 vaccine made <XB>
11 	 12 	 ((S\NP)\(S\NP))/NP 	 2 	 made by
14 	 12 	 ((S\NP)\(S\NP))/NP 	 3 	 Inc. by
14 	 13 	 N/N 	 1 	 Inc. MicroGeneSys
14 	 15 	 (NP\NP)/NP 	 1 	 Inc. of
17 	 15 	 (NP\NP)/NP 	 2 	 Haven of
17 	 16 	 N/N 	 1 	 Haven West
19 	 15 	 (NP\NP)/NP 	 2 	 Conn. of
21 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 came at
21 	 29 	 ((S\NP)\(S\NP))/NP 	 2 	 came in
21 	 32 	 (S\NP)\(S\NP) 	 2 	 came Monday
24 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 meeting at
24 	 23 	 NP[nb]/N 	 1 	 meeting a
24 	 25 	 (NP\NP)/NP 	 1 	 meeting of
28 	 25 	 (NP\NP)/NP 	 2 	 researchers of
28 	 26 	 N/N 	 1 	 researchers AIDS
28 	 27 	 N/N 	 1 	 researchers vaccine
30 	 29 	 ((S\NP)\(S\NP))/NP 	 3 	 Florida in
32 	 31 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 Monday late
<\s>
<s id="wsj_2078.5"> 24
1 	 0 	 NP[nb]/N 	 1 	 vaccine The
1 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 vaccine has
1 	 9 	 (S[pss]\NP)/PP 	 1 	 vaccine given <XB>
4 	 3 	 N/N 	 1 	 HIV-1 VaxSyn
4 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 HIV-1 has
4 	 9 	 (S[pss]\NP)/PP 	 1 	 HIV-1 given <XB>
7 	 6 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
9 	 7 	 (S[pt]\NP)/(S[pss]\NP) 	 2 	 given been
9 	 8 	 (S\NP)/(S\NP) 	 2 	 given safely
10 	 9 	 (S[pss]\NP)/PP 	 2 	 to given
12 	 10 	 PP/NP 	 1 	 people to
12 	 11 	 N/N 	 1 	 people 14
12 	 16 	 ((NP\NP)/(S[dcl]\NP))\(NP/NP) 	 1 	 people whom
14 	 15 	 (NP\NP)/NP 	 1 	 some of
14 	 16 	 ((NP\NP)/(S[dcl]\NP))\(NP/NP) 	 3 	 some whom
17 	 16 	 ((NP\NP)/(S[dcl]\NP))\(NP/NP) 	 2 	 are whom
18 	 17 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 experiencing are
20 	 18 	 (S[ng]\NP)/NP 	 2 	 increases experiencing
20 	 19 	 N/N 	 1 	 increases substantial
20 	 21 	 (NP\NP)/NP 	 1 	 increases in
23 	 21 	 (NP\NP)/NP 	 2 	 antibodies in
23 	 22 	 N/N 	 1 	 antibodies certain
<\s>
<s id="wsj_2078.6"> 29
2 	 0 	 NP[nb]/N 	 1 	 wisdom The
2 	 1 	 N/N 	 1 	 wisdom conventional
2 	 3 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 wisdom used
2 	 5 	 (S[b]\NP)/S[em] 	 1 	 wisdom be <XB>
3 	 28 	 (S[dcl]\S[dcl])\NP 	 1 	 used said
4 	 3 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to used
5 	 4 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
6 	 5 	 (S[b]\NP)/S[em] 	 2 	 that be
7 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 you could
7 	 10 	 (S[b]\NP)/NP 	 1 	 you modify <XB>
7 	 19 	 ((S[ng]\NP)/PP)/NP 	 1 	 you innoculating <XB>
8 	 6 	 S[em]/S[dcl] 	 1 	 could that
8 	 9 	 (S\NP)\(S\NP) 	 2 	 could n't
10 	 8 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 modify could
10 	 18 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 modify by
13 	 10 	 (S[b]\NP)/NP 	 2 	 response modify
13 	 11 	 NP[nb]/N 	 1 	 response the
13 	 12 	 N/N 	 1 	 response immune
13 	 14 	 (NP\NP)/NP 	 1 	 response of
17 	 14 	 (NP\NP)/NP 	 2 	 individual of
17 	 15 	 NP[nb]/N 	 1 	 individual an
17 	 16 	 N/N 	 1 	 individual infected
19 	 18 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 innoculating by
20 	 19 	 ((S[ng]\NP)/PP)/NP 	 3 	 them innoculating
21 	 19 	 ((S[ng]\NP)/PP)/NP 	 2 	 with innoculating
24 	 21 	 PP/NP 	 1 	 proteins with
24 	 22 	 N/N 	 1 	 proteins synthetic
24 	 23 	 N/N 	 1 	 proteins viral
27 	 26 	 N/N 	 1 	 Redfield Dr.
27 	 28 	 (S[dcl]\S[dcl])\NP 	 2 	 Redfield said
<\s>
<s id="wsj_2078.7"> 6
0 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 We 've
0 	 2 	 (S[pt]\NP)/S[em] 	 1 	 We demonstrated <XB>
2 	 1 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 demonstrated 've
3 	 2 	 (S[pt]\NP)/S[em] 	 2 	 that demonstrated
4 	 5 	 S[dcl]\NP 	 1 	 you can
5 	 3 	 S[em]/S[dcl] 	 1 	 can that
<\s>
<s id="wsj_2078.8"> 12
0 	 1 	 (S[dcl]\NP)/S[dcl] 	 1 	 He said
3 	 2 	 N/N 	 1 	 volunteers certain
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 volunteers developed
4 	 1 	 (S[dcl]\NP)/S[dcl] 	 2 	 developed said
5 	 4 	 (S[dcl]\NP)/NP 	 2 	 kinds developed
5 	 6 	 (NP\NP)/NP 	 1 	 kinds of
5 	 8 	 (S[pss]\NP)/PP 	 1 	 kinds associated <XB>
7 	 6 	 (NP\NP)/NP 	 2 	 antibodies of
9 	 8 	 (S[pss]\NP)/PP 	 2 	 with associated
11 	 9 	 PP/NP 	 1 	 AIDS with
11 	 10 	 N/N 	 1 	 AIDS early
<\s>
<s id="wsj_2078.9"> 23
1 	 0 	 N/N 	 1 	 antibodies Other
1 	 2 	 S[pss]\NP 	 1 	 antibodies sparked <XB>
1 	 6 	 (S[dcl]\NP)/PP 	 1 	 antibodies are
2 	 3 	 ((S\NP)\(S\NP))/NP 	 2 	 sparked by
5 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 preparation by
5 	 4 	 NP[nb]/N 	 1 	 preparation the
6 	 22 	 (S[dcl]\S[dcl])\NP 	 1 	 are added
7 	 6 	 (S[dcl]\NP)/PP 	 2 	 of are
9 	 7 	 PP/NP 	 1 	 sort of
9 	 8 	 NP[nb]/N 	 1 	 sort a
9 	 11 	 S[adj]\NP 	 1 	 sort present <XB>
11 	 10 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 present rarely
11 	 12 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 present in
11 	 15 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 2 	 present in
14 	 12 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 quantities in
14 	 13 	 N/N 	 1 	 quantities large
19 	 15 	 ((S[adj]\NP)\(S[adj]\NP))/NP 	 3 	 individuals in
19 	 16 	 N/N 	 1 	 individuals infected <XU>
19 	 18 	 N/N 	 1 	 individuals ill
21 	 22 	 (S[dcl]\S[dcl])\NP 	 2 	 he added
<\s>
<s id="wsj_2078.10"> 19
0 	 1 	 (NP\NP)/NP 	 1 	 One of
0 	 6 	 (S[dcl]\NP)/S[qem] 	 1 	 One remains
3 	 1 	 (NP\NP)/NP 	 2 	 mysteries of
3 	 2 	 NP[nb]/N 	 1 	 mysteries the
3 	 4 	 (NP\NP)/NP 	 1 	 mysteries of
5 	 4 	 (NP\NP)/NP 	 2 	 AIDS of
7 	 6 	 (S[dcl]\NP)/S[qem] 	 2 	 why remains
9 	 8 	 N/N 	 1 	 people infected
9 	 10 	 (S[dcl]\NP)/NP 	 1 	 people produce
9 	 17 	 S[dcl]\NP 	 1 	 people deteriorate <XU>
10 	 7 	 S[qem]/S[dcl] 	 1 	 produce why
12 	 10 	 (S[dcl]\NP)/NP 	 2 	 quantities produce
12 	 11 	 N/N 	 1 	 quantities large
12 	 13 	 (NP\NP)/NP 	 1 	 quantities of
14 	 13 	 (NP\NP)/NP 	 2 	 antibodies of
17 	 7 	 S[qem]/S[dcl] 	 1 	 deteriorate why
17 	 18 	 (S\NP)\(S\NP) 	 2 	 deteriorate nonetheless
<\s>
